|
Total properties:
44
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/05/2016
|
Application #:
|
14212656
|
Filing Dt:
|
03/14/2014
|
|
Publication #:
|
|
Pub Dt:
|
09/25/2014
| | | | |
|
Title:
|
COVALENT INHIBITORS OF KRAS G12C
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/12/2017
|
Application #:
|
14511425
|
Filing Dt:
|
10/10/2014
|
|
Publication #:
|
|
Pub Dt:
|
08/27/2015
| | | | |
|
Title:
|
SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
08/29/2017
|
Application #:
|
14777334
|
Filing Dt:
|
09/15/2015
|
|
Publication #:
|
|
Pub Dt:
|
02/04/2016
| | |
PCT #:
|
US2014027454
|
|
Title:
|
IRREVERSIBLE COVALENT INHIBITORS OF THE GTPASE K-RAS G12C
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/30/2018
|
Application #:
|
14858766
|
Filing Dt:
|
09/18/2015
|
|
Publication #:
|
|
Pub Dt:
|
06/16/2016
| | | | |
|
Title:
|
COMBINATION THERAPIES FOR TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/09/2018
|
Application #:
|
14866147
|
Filing Dt:
|
09/25/2015
|
|
Publication #:
|
|
Pub Dt:
|
04/21/2016
| | | | |
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/27/2018
|
Application #:
|
14933734
|
Filing Dt:
|
11/05/2015
|
|
Publication #:
|
|
Pub Dt:
|
06/09/2016
| | | | |
|
Title:
|
COVALENT INHIBITORS OF KRAS G12C
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/02/2019
|
Application #:
|
15093951
|
Filing Dt:
|
04/08/2016
|
|
Publication #:
|
|
Pub Dt:
|
10/13/2016
| | | | |
|
Title:
|
SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/04/2018
|
Application #:
|
15217304
|
Filing Dt:
|
07/22/2016
|
|
Publication #:
|
|
Pub Dt:
|
01/26/2017
| | | | |
|
Title:
|
SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/17/2019
|
Application #:
|
15353402
|
Filing Dt:
|
11/16/2016
|
|
Publication #:
|
|
Pub Dt:
|
07/13/2017
| | | | |
|
Title:
|
2-SUBSTITUTED QUINAZOLINE COMPOUNDS COMPRISING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/05/2018
|
Application #:
|
15373832
|
Filing Dt:
|
12/09/2016
|
|
Publication #:
|
|
Pub Dt:
|
07/06/2017
| | | | |
|
Title:
|
METHODS FOR PREPARATION OF QUINAZOLINE DERIVATIVES
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
10/01/2019
|
Application #:
|
15566648
|
Filing Dt:
|
10/13/2017
|
|
Publication #:
|
|
Pub Dt:
|
03/29/2018
| | |
PCT #:
|
US2016027673
|
|
Title:
|
FUSED-TRICYCLIC INHIBITORS OF KRAS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/12/2020
|
Application #:
|
15649568
|
Filing Dt:
|
07/13/2017
|
|
Publication #:
|
|
Pub Dt:
|
01/18/2018
| | | | |
|
Title:
|
CONJUGATES OF CEREBLON BINDING COMPOUNDS AND G12C MUTANT KRAS, HRAS OR NRAS PROTEIN MODULATING COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/07/2019
|
Application #:
|
15721021
|
Filing Dt:
|
09/29/2017
|
|
Publication #:
|
|
Pub Dt:
|
06/07/2018
| | | | |
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/13/2019
|
Application #:
|
15727422
|
Filing Dt:
|
10/06/2017
|
|
Publication #:
|
|
Pub Dt:
|
05/10/2018
| | | | |
|
Title:
|
INHIBITORS OF RAS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
05/12/2020
|
Application #:
|
15763798
|
Filing Dt:
|
03/27/2018
|
|
Publication #:
|
|
Pub Dt:
|
10/04/2018
| | |
PCT #:
|
US2016053923
|
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
12/08/2020
|
Application #:
|
15763802
|
Filing Dt:
|
03/27/2018
|
|
Publication #:
|
|
Pub Dt:
|
09/27/2018
| | |
PCT #:
|
US2016053774
|
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
08/04/2020
|
Application #:
|
15763806
|
Filing Dt:
|
03/27/2018
|
|
Publication #:
|
|
Pub Dt:
|
09/27/2018
| | |
PCT #:
|
US2016053987
|
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
01/05/2021
|
Application #:
|
15763812
|
Filing Dt:
|
03/27/2018
|
|
Publication #:
|
|
Pub Dt:
|
10/04/2018
| | |
PCT #:
|
US2016053957
|
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
12/29/2020
|
Application #:
|
15764076
|
Filing Dt:
|
03/28/2018
|
|
Publication #:
|
|
Pub Dt:
|
11/08/2018
| | |
PCT #:
|
US2016053990
|
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
06/23/2020
|
Application #:
|
15764088
|
Filing Dt:
|
03/28/2018
|
|
Publication #:
|
|
Pub Dt:
|
02/21/2019
| | |
PCT #:
|
US2016054164
|
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
04/13/2021
|
Application #:
|
15764097
|
Filing Dt:
|
11/13/2018
|
|
Publication #:
|
|
Pub Dt:
|
03/28/2019
| | |
PCT #:
|
US2016054179
|
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/06/2019
|
Application #:
|
15805716
|
Filing Dt:
|
11/07/2017
|
|
Publication #:
|
|
Pub Dt:
|
05/03/2018
| | | | |
|
Title:
|
SUBSTITUTED QUINOLINES AS INHIBITORS OF KRAS G12C
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15817075
|
Filing Dt:
|
11/17/2017
|
|
Publication #:
|
|
Pub Dt:
|
05/24/2018
| | | | |
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/30/2019
|
Application #:
|
15891304
|
Filing Dt:
|
02/07/2018
|
|
Publication #:
|
|
Pub Dt:
|
06/14/2018
| | | | |
|
Title:
|
COVALENT INHIBITORS OF KRAS G12C
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/16/2019
|
Application #:
|
15916075
|
Filing Dt:
|
03/08/2018
|
|
Publication #:
|
|
Pub Dt:
|
07/12/2018
| | | | |
|
Title:
|
SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/18/2020
|
Application #:
|
15989015
|
Filing Dt:
|
05/24/2018
|
|
Publication #:
|
|
Pub Dt:
|
02/28/2019
| | | | |
|
Title:
|
COVALENT INHIBITORS OF KRAS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/11/2020
|
Application #:
|
15989031
|
Filing Dt:
|
05/24/2018
|
|
Publication #:
|
|
Pub Dt:
|
02/28/2019
| | | | |
|
Title:
|
COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16141775
|
Filing Dt:
|
09/25/2018
|
|
Publication #:
|
|
Pub Dt:
|
08/29/2019
| | | | |
|
Title:
|
COMBINATION THERAPIES FOR TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/10/2020
|
Application #:
|
16281905
|
Filing Dt:
|
02/21/2019
|
|
Publication #:
|
|
Pub Dt:
|
09/19/2019
| | | | |
|
Title:
|
SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/16/2021
|
Application #:
|
16355258
|
Filing Dt:
|
03/15/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/26/2019
| | | | |
|
Title:
|
COVALENT INHIBITORS OF KRAS G12C
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/28/2020
|
Application #:
|
16374356
|
Filing Dt:
|
04/03/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/27/2020
| | | | |
|
Title:
|
INHIBITORS OF KRAS G12C MUTANT PROTEINS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/23/2021
|
Application #:
|
16449967
|
Filing Dt:
|
06/24/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/02/2020
| | | | |
|
Title:
|
SUBSTITUTED CINNOLINES AS INHIBITORS OF KRAS G12C
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/22/2022
|
Application #:
|
16480195
|
Filing Dt:
|
07/23/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/19/2019
| | |
PCT #:
|
US2018015071
|
|
Title:
|
1-(3-(6-(3-HYDROXYNAPHTHALEN-1-YL)BENZOFURAN-2-YL)AZETIDIN-1 YL)PROP-2-EN-1-ONE DERIVATIVES AND SIMILAR COMPOUNDS AS KRAS G12C MODULATORS FOR TREATING CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/05/2021
|
Application #:
|
16480205
|
Filing Dt:
|
07/23/2019
|
|
Publication #:
|
|
Pub Dt:
|
01/09/2020
| | |
PCT #:
|
US2018015072
|
|
Title:
|
SUBSTITUTED QUINAZOLINE AND QUINAZOLINONE COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/15/2022
|
Application #:
|
16480211
|
Filing Dt:
|
07/23/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/05/2019
| | |
PCT #:
|
US2018015070
|
|
Title:
|
FUSED BICYCLIC BENZOHETEROAROMATIC COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16480849
|
Filing Dt:
|
07/25/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/10/2020
| | |
PCT #:
|
US2018015227
|
|
Title:
|
FUSED N-HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/14/2022
|
Application #:
|
16480861
|
Filing Dt:
|
07/25/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/26/2019
| | |
PCT #:
|
US2018015232
|
|
Title:
|
BENZOTHIOPHENE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
07/13/2021
|
Application #:
|
16480874
|
Filing Dt:
|
07/25/2019
|
|
Publication #:
|
|
Pub Dt:
|
11/14/2019
| | |
PCT #:
|
US2018015233
|
|
Title:
|
FUSED HETERO-HETERO BICYCLIC COMPOUNDS AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/01/2021
|
Application #:
|
16514675
|
Filing Dt:
|
07/17/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/11/2020
| | | | |
|
Title:
|
2-SUBSTITUTED QUINAZOLINE COMPOUNDS COMPRISING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF USE THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/02/2023
|
Application #:
|
16616066
|
Filing Dt:
|
11/22/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/16/2020
| | |
PCT #:
|
US2018034470
|
|
Title:
|
QUINAZOLINE DERIVATIVES AS MODULATORS OF MUTANT KRAS, HRAS OR NRAS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/05/2022
|
Application #:
|
16915942
|
Filing Dt:
|
06/29/2020
|
|
Publication #:
|
|
Pub Dt:
|
01/28/2021
| | | | |
|
Title:
|
COVALENT INHIBITORS OF KRAS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17264744
|
Filing Dt:
|
01/29/2021
|
|
Publication #:
|
|
Pub Dt:
|
10/14/2021
| | |
PCT #:
|
US2019044729
|
|
Title:
|
HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17287473
|
Filing Dt:
|
04/21/2021
|
|
Publication #:
|
|
Pub Dt:
|
12/09/2021
| | |
PCT #:
|
US2019057694
|
|
Title:
|
2-(2-ACRYLOYL-2,6-DIAZASPIRO[3.4]OCTAN-6-YL)-6-(1H-INDAZOL-4-YL)-BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF G12C MUTANT KRAS PROTEIN FOR INHIBITING TUMOR METASTASIS
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17298409
|
Filing Dt:
|
05/28/2021
|
|
Publication #:
|
|
Pub Dt:
|
04/14/2022
| | |
PCT #:
|
US2019063702
|
|
Title:
|
COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER
|
|
